This Gut Molecule Renews Mitochondria & Saves Aging Cells

Discover how the gut microbiome metabolite Urolithin A clears damaged mitochondria, reverses immune senescence, and suppresses chronic inflammation. We break down the latest human clinical trial published in Nature Aging and mechanistic data from the Buck Institute showing how targeted mitophagy restores youthful cellular energy. 🔬 Special Offer: Support your mitochondrial renewal and cellular recycling with Timeline Nutrition (Mitopure). Get 10% off using code MODERN at: https://timeline.sjv.io/k4JrNx Most longevity research focuses on creating new cellular components, but clearing out damaged, toxic mitochondria is equally critical for healthy lifespan. When mitochondria malfunction with age, they leak reactive oxygen species and mitochondrial DNA (mtDNA) into the cytosol, triggering the cGAS-STING inflammatory pathway and driving cells into irreversible cellular senescence. In this video, we break down landmark human clinical trials and preclinical studies evaluating Urolithin A, a potent postbiotic activator of mitophagy. We examine the randomized double-blind MitoIMMUNE trial published in Nature Aging, showing that 1,000 mg of Urolithin A daily for 28 days remodeled exhausted CD8+ T cells, expanded naive memory pools, and shifted cellular metabolism toward fatty acid oxidation. We also review human trials in JAMA Network Open and Cell Reports Medicine showing improved muscle endurance and VO2 max, explore why 60% to 70% of humans cannot produce Urolithin A from diet alone, and cover optimal dosing protocols, lipid absorption strategies, and key industry funding disclosures. 00:00 The Cellular Recycling Dilemma & Mitophagy 01:29 The MitoIMMUNE Trial: Rejuvenating Human T Cells 03:15 Reversing Immunosenescence & Restoring Memory T Cells 04:49 Muscle Endurance & Mitochondrial Health Trials 05:12 How Mitophagy Halts Cellular Senescence (cGAS-STING) 07:04 The Microbiome Bottleneck: Ellagitannins vs. Pure Urolithin A 08:06 Optimal Dosing & Fat-Soluble Bioavailability Protocol 09:01 Critical Limitations, Industry Funding & Exercise Synergy #UrolithinA #Mitophagy #Longevity Disclaimer: The information provided in this video is for educational and informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or health objectives. Scientific References: - MitoIMMUNE Clinical Trial: Denk, D., et al. (2025). Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial. Nature Aging. ClinicalTrials.gov Identifier: NCT05735886 (https://clinicaltrials.gov/study/NCT05735886) - Mitophagy & Senescence Mechanisms: Ballesteros-Alvarez, J., Andersen, J.K., et al. Buck Institute for Research on Aging. Urolithin A reduces cytosolic mtDNA leakage, suppresses cGAS-STING inflammation, and extends lifespan in model organisms. - Human Muscle Endurance Trial (JAMA): Liu, P.Z., et al. (2022). Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Network Open, 5(5):e2210735. https://doi.org/10.1001/jamanetworkopen.2022.10735 - Middle-Aged Clinical Trial: Singh, A., et al. (2022). Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Reports Medicine, 3(5):100633. https://doi.org/10.1016/j.xcrm.2022.100633